Research & Development



  “哦。”陸昔年吐了吐舌頭,乖乖應下,經過貨架的時候拿了一盒香菇放進購物車里。   要不然逛逛論壇?這個想法剛冒出來就被他壓了下去,答應過林徵羽不逛就是不逛!成av人电影在线观看   雖然他是這麼說過沒錯。伊人   我想吃年糕,那個常年佔據他沙發的微博小號!   陸昔年想吐槽他,忽然想起林徵羽之前說過的話︰我不自戀,我戀你。耳尖一紅,到嘴邊的話又給咽了下去。2014av手机天堂网免费   說完這句,林徵羽腳下生風的回到廚房,還不忘將門帶上。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo